3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Waldenstrom Macroglobulinemia
1
Solitary Fibrous Tumor, Pleural
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Mesothelioma, Malignant
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Glioma
1
Fallopian Tube Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Chondrosarcoma, Mesenchymal
1
Chondrosarcoma, Clear Cell
1
Chondrosarcoma
1
Anemia
1
Anatomic Stage III Breast Cancer AJCC v8
1
Adult Patients Who Are Receiving Oncologic Care
1
Interventions
Temozolomide
4
Specimen Handling
2
tovorafenib
1
spartalizumab
1
ribociclib
1
pembrolizumab
1
olutasidenib
1
lutetium Lu 177 dotatate
1
larotrectinib
1
balstilimab
1
Vaccines
1
Receptors, Interleukin-8B
1
Radiotherapy
1
Pharmacogenomic Variants
1
Pharmacogenomic Testing
1
PTC596
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Injections
1
Immune Checkpoint Inhibitors
1
Fluid Therapy
1
Everolimus
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
Diffusion Tensor Imaging
1
Cilengitide
1
CLR1404
1
CBLC137
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Diffuse Intrinsic Pontine Glioma
×
Pharmacogenomic Testing
×
90 days
×
Clear all
NCT01165333
2026-03-16
CILENT
Centre Oscar Lambret
Phase 1
Completed
32 enrolled